Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcificationMiguel D. Ferrer, Joan Perelló, Eva Tur et al.|PLoS ONE|2018Cited by 51
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxisJoan Perelló, Carolina Salcedo, Alex Gold et al.|British Journal of Pharmacology|2020Cited by 48
A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasmaMiguel D. Ferrer, Joan Perelló, M. Mar Perez et al.|Scientific Reports|2017Cited by 40
First‐time‐in‐human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcificationJoan Perelló, C. Salcedo, Pieter Joubert et al.|British Journal of Clinical Pharmacology|2018Cited by 37